ストックスクリーナーアプリを入手
0.272
2.51%
-0.007
前日終値:
$0.279
開ける：
$0.2786
24時間の取引高:
455.30K
Relative Volume:
0.38
時価総額：
$28.39M
収益：
$1.27M
当期純損益:
$-7.12M
株価収益率:
-5.2107
EPS:
-0.0522
ネットキャッシュフロー:
$-5.28M
1週間 パフォーマンス:
-3.17%
1か月 パフォーマンス:
-3.20%
6か月 パフォーマンス:
-9.42%
1年 パフォーマンス:
-34.46%
1日の値動き範囲:
$0.2693
$0.2839
1週間の範囲:
$0.269
$0.2941
52週間の値動き範囲:
$0.242
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Compare IGC vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.272 | 28.39M | 1.27M | -7.12M | -5.28M | -0.0522 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
IGC Pharma Inc (IGC) 最新ニュース
IGC Pharma to Showcase AI Portfolio at AAIC 2026, Including AHA Platform That Reduced Alzheimer's Data Harmonization Time by 90% in Representative Workflow - Black Hills Pioneer
IGC Pharma Showcases AI Portfolio at AAIC 2026 - ACCESS Newswire
IGC Pharma puts AI tools on display for Alzheimer’s research in London - Stock Titan
IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast - Sweetwater Reporter
IGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer's Drug - openPR.com
FinancialContentIGC Pharma (NYSE: IGC) CEO Discusses AI, Alzheimer’s Drug Development and Key 2026 Catalysts on The Street Podcast - FinancialContent
IGC Pharma (NYSE: IGC) CEO discusses AI, Alzheimer's drug development and key 2026 catalysts on The Street podcast - MSN
IGC: CEO and CFO Acquire 4.27 Million Shares in Company Stock - GuruFocus
IGC Pharma CEO and Principal Financial Officer Purchase More Than $1.15 Million of Common Stock Directly from the Company - BioSpace
IGC Pharma CEO, finance chief buy $1.15M of common stock - MSN
IGC Pharma chief executives swap $1.15M debt for restricted shares - Stock Titan
IGC Pharma Executives Convert Debt Into Equity Shares - TipRanks
Executives convert $1,154,210 owed into IGC (NYSE: IGC) stock - Stock Titan
IGC Pharma Converts $1.15M Insider Debt Into Equity at $0.27 in Private Issuance - TradingView
IGCIGC Pharma Inc Revenue Breakdown - Finviz
IGC Pharma (NYSE: IGC) CEO and CFO Acquire More Than 4.2 Million Shares - marketscreener.com
Form 4 IGC Pharma Inc For: 1 July By Investing.com - Investing.com Nigeria
IGC Pharma (IGC) CEO converts $601K company debt into 2.23M shares - Stock Titan
Debt-for-equity swap gives IGC Pharma (IGC) PFO 2.0M new shares - Stock Titan
Stocks Under $1: TNMG, SRFM, PRSO, KNDI, IGC Offer Multibagger Potential as AI Boom Accelerates - openPR.com
MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now - openPR.com
IGC Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock UptickReturn On Capital - dars.gov.et
Enterprise value to revenue forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
IGC Pharma, Inc. Actuals & Estimates (AMEX:IGC) - TradingView
IGC Pharma, Inc. Actuals & Estimates (SWB:IGS1) - TradingView
Enterprise value to EBITDA forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
Enterprise value to EBITDA forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
IGC Pharma, Inc. Actuals & Estimates (DUS:IGS1) - TradingView
Enterprise value to EBIT forward of IGC Pharma, Inc. – AMEX:IGC - TradingView
IGC Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
Enterprise value to EBIT forward of IGC Pharma, Inc. – TRADEGATE:IGS1 - TradingView
IGC Pharma’s (NYSE American: IGC) AI Platform Cuts Alzheimer’s Research by 90%, Accelerating Drug Discovery - Barchart.com
IGC Unveils AI Platform to Enhance Alzheimer's Data Integration - GuruFocus
IGC Pharma's AHA Agentic AI Platform Reduces Alzheimer's Data Harmonization Time by 90% in Representative Workflow - ACCESS Newswire
IGC Pharma's AI tool cuts Alzheimer’s data prep from 28 hours to 2.5 - Stock Titan
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA - Mid Florida Newspapers
IGC Pharma Inc (IGC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IGC Pharma Inc (IGC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IGC Pharma Inc (IGC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IGC Pharma Inc (IGC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IGC Pharma Inc (IGC) Institutional Confidence - TradingKey
IGC Pharma Inc (IGC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IGC Pharma Inc (IGC) Valuation: PE, PB & Fair Value Analysis - TradingKey
IGC Pharma Inc (IGC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IGC Pharma Inc (IGC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IGC Pharma Reaches Previously Disclosed 146-Patient Enrollment Target in Phase 2 CALMA Trial, Advancing Toward Topline Analysis - ACCESS Newswire
IGC Reaches Enrollment Milestone in Alzheimer's Dementia Trial - GuruFocus
IGC Pharma (NYSE American: IGC) Alzheimer's Drug Gains Attention After Ascendiant Capital Raises Price Target - openPR.com
IGC Pharma (IGC) Inches Up 1.78% as It Approaches Key ResistanceSwing Entry Signals - newsline.com
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight - 富途牛牛
IGC Pharma Inc (IGC) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):